The stock of Xtant Medical Holdings Inc (XTNT) has gone down by 0.00% for the week, with a -6.36% drop in the past month and a -14.17% drop in the past quarter. The volatility ratio for the week is 13.63%, and the volatility levels for the past 30 days are 9.67% for XTNT. The simple moving average for the past 20 days is -7.58% for XTNT’s stock, with a -5.95% simple moving average for the past 200 days.
Is It Worth Investing in Xtant Medical Holdings Inc (AMEX: XTNT) Right Now?
The 36-month beta value for XTNT is at 0.21. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for XTNT is 45.11M, and currently, shorts hold a 0.43% of that float. The average trading volume for XTNT on April 02, 2024 was 121.40K shares.
XTNT) stock’s latest price update
The stock price of Xtant Medical Holdings Inc (AMEX: XTNT) has dropped by -11.97 compared to previous close of 1.17. GlobeNewsWire reported 2024-03-21 that BELGRADE, Mont., March 21, 2024 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2023, before the open of the financial markets on Monday, April 1, 2024.
Analysts’ Opinion of XTNT
Many brokerage firms have already submitted their reports for XTNT stocks, with BTIG Research repeating the rating for XTNT by listing it as a “Buy.” The predicted price for XTNT in the upcoming period, according to BTIG Research is $2 based on the research report published on December 05, 2023 of the previous year 2023.
Maxim Group, on the other hand, stated in their research note that they expect to see XTNT reach a price target of $6, previously predicting the price at $10. The rating they have provided for XTNT stocks is “Buy” according to the report published on November 15th, 2018.
Maxim Group gave a rating of “Buy” to XTNT, setting the target price at $10 in the report published on February 14th of the previous year.
XTNT Trading at -4.67% from the 50-Day Moving Average
After a stumble in the market that brought XTNT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.97% of loss for the given period.
Volatility was left at 9.67%, however, over the last 30 days, the volatility rate increased by 13.63%, as shares sank -11.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.50% lower at present.
During the last 5 trading sessions, XTNT remain unchanged, which changed the moving average for the period of 200-days by +60.94% in comparison to the 20-day moving average, which settled at $1.1075. In addition, Xtant Medical Holdings Inc saw -8.85% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at XTNT starting from Brandt Kevin D, who purchase 41,670 shares at the price of $1.20 back on Nov 17 ’23. After this action, Brandt Kevin D now owns 815,860 shares of Xtant Medical Holdings Inc, valued at $49,837 using the latest closing price.
Stock Fundamentals for XTNT
Current profitability levels for the company are sitting at:
- -0.1 for the present operating margin
- 0.59 for the gross margin
The net margin for Xtant Medical Holdings Inc stands at 0.04. The total capital return value is set at -0.12. Equity return is now at value 1.54, with 0.86 for asset returns.
Based on Xtant Medical Holdings Inc (XTNT), the company’s capital structure generated 0.3 points at debt to capital in total, while cash flow to debt ratio is standing at -0.47. The debt to equity ratio resting at 0.42. The interest coverage ratio of the stock is -7.37.
Currently, EBITDA for the company is -10.16 million with net debt to EBITDA at -2.15. When we switch over and look at the enterprise to sales, we see a ratio of 1.89. The receivables turnover for the company is 4.1for trailing twelve months and the total asset turnover is 0.85. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.82.
Conclusion
In conclusion, Xtant Medical Holdings Inc (XTNT) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
